(Q55042063)

English

Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.

scientific article

Statements

Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit